Patents by Inventor Pierre Lestage

Pierre Lestage has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030195216
    Abstract: A compound selected from those of formula (I): 1
    Type: Application
    Filed: July 12, 2002
    Publication date: October 16, 2003
    Inventors: Solo Goldstein, Guillaume Poissonnet, Jean-Gilles Parmentier, Pierre Lestage, Brian Lockhart
  • Publication number: 20030181484
    Abstract: The invention relates to a compound of formula (I): 1
    Type: Application
    Filed: March 3, 2003
    Publication date: September 25, 2003
    Inventors: Otto Meth-Cohn, Chu-Yi Yu, Pierre Lestage, Marie-Cecile Lebrun, Daniel-Henri Caignard, Pierre Renard
  • Publication number: 20030139408
    Abstract: The invention relates to a compound of formula (I): 1
    Type: Application
    Filed: November 27, 2002
    Publication date: July 24, 2003
    Inventors: Otto Meth-Cohn, Chu-Yi Yu, Pierre Lestage, Marie-Cecile Lebrun, Daniel-Henri Caignard, Pierre Renard
  • Patent number: 6596709
    Abstract: The invention relates to a compound of formula (I): wherein: X represents chlorine or fluorine or CF3, R represents hydrogen or a group and methods for using the same.
    Type: Grant
    Filed: December 9, 2002
    Date of Patent: July 22, 2003
    Assignee: Les Laboratoires Servier
    Inventors: Alex Cordi, Patrice Desos, Pierre Lestage
  • Patent number: 6518258
    Abstract: The invention relates to a compound of formula (I): wherein: X represents chlorine or fluorine or CF3, R represents hydrogen or a group and methods for using the same.
    Type: Grant
    Filed: February 14, 2001
    Date of Patent: February 11, 2003
    Assignee: Les Laboratoires Servier
    Inventors: Alex Cordi, Patrice Desos, Pierre Lestage
  • Patent number: 6511992
    Abstract: The invention relates to a compound of formula (I): wherein: A represents pyridine, pyridinium or piperidine R1, R2, R3 and R4 are as defined in the description R5 represents hydrogen, a nitrogen-containing heterocycle or a group of formula (II) R6 represents hydrogen or linear or branched (C1-C6)alkyl; and medicinal products containing the same which are useful in treating pain or deficiencies in memory.
    Type: Grant
    Filed: September 25, 2001
    Date of Patent: January 28, 2003
    Assignee: les Laboratories Servier
    Inventors: Otto Meth-Cohn, Chu-Yi Yu, Pierre Lestage, Marie-Cécile Lebrun, Daniel-Henri Caignard, Pierre Renard
  • Patent number: 6486143
    Abstract: The invention relates to a compound of formula (I): wherein: R1 represents halogen or a group CF3, R2 represents hydrogen or alkyl or cycloalkyl, R3 is as defined in the description, R4 and R5 represent hydrogen or alkyl, cycloalkyl, aryl or arylalkyl a group Medicaments.
    Type: Grant
    Filed: February 15, 2001
    Date of Patent: November 26, 2002
    Assignee: Les Laboratoires Servier
    Inventors: Alex Cordi, Patrice Desos, Pierre Lestage
  • Patent number: 6451789
    Abstract: Compound of formula (I): wherein: n represents 0 or 1, R1 represents hydrogen, arylalkyl, alkyl, acyl, alkoxycarbonyl, arylalkoxycarbonyl or trifluoroacetyl, R2 represents alkyl, X represents oxygen, chlorine, OR3, SR4 or NOR5, R3 represents hydrogen , alkyl, acyl, alkoxycarbonyl or arylalkoxycarbonyl, R4 represents hydrogen, alkyl or aryl, R5 represents hydrogen or optionally substituted alkyl, represents a single or double bond, Ar represents aryl or heteroaryl, its isomers and addition salts thereof with a pharmaceutically acceptable acid, and medicinal products containing the same which are useful as facilitators of memory and cognition and antalgic agents.
    Type: Grant
    Filed: September 26, 2001
    Date of Patent: September 17, 2002
    Assignee: Les Labortoires Servier
    Inventors: Sylvain Rault, Olivier Renault, Jean Guillon, Patrick Dallemagne, Pierre Renard, Bruno Pfeiffer, Pierre Lestage, Marie-Cécile Lebrun
  • Patent number: 6420386
    Abstract: The invention relates to a compound of formula (I): wherein: R1 represents halogen or a group CF3, R2 represents aryl or heteroaryl, R3 and R4 are as defined in the description and methods for using the same.
    Type: Grant
    Filed: February 14, 2001
    Date of Patent: July 16, 2002
    Assignee: Les Laboratories Servier
    Inventors: Alex Cordi, Patrice Desos, Pierre Lestage
  • Publication number: 20020042413
    Abstract: Compound of formula (I): 1
    Type: Application
    Filed: September 26, 2001
    Publication date: April 11, 2002
    Inventors: Sylvain Rault, Olivier Renault, Jean Guillon, Patrick Dallemagne, Pierre Renard, Bruno Pfeiffer, Pierre Lestage, Marie-Cecile Lebrun
  • Publication number: 20020040036
    Abstract: The invention relates to a compound of formula (I): 1
    Type: Application
    Filed: September 25, 2001
    Publication date: April 4, 2002
    Applicant: ADIR ET COMPAGNIE
    Inventors: Otto Meth-Cohn, Chu-Yi Yu, Pierre Lestage, Marie-Cecile Lebrun, Daniel-Henri Caignard, Pierre Renard
  • Publication number: 20020037894
    Abstract: Compound of formula (I): 1
    Type: Application
    Filed: July 27, 2001
    Publication date: March 28, 2002
    Inventors: Alex Cordi, Patrice Desos, Francois Lefoulon, Pierre Lestage
  • Publication number: 20020035123
    Abstract: The invention relates to a compound of formula (I): 1
    Type: Application
    Filed: September 25, 2001
    Publication date: March 21, 2002
    Applicant: ADIR ET COMPAGNIE
    Inventors: Otto Meth-Cohn, Chu-Yi Yu, Pierre Lestage, Marie-Cecile Lebrun, Daniel-Henri Caignard, Pierre Renard
  • Patent number: 6350759
    Abstract: Compound of formula (I): wherein: R1 represents hydrogen or wherein A is as defined in the description, R2 and R3 each independently represents alkyl, cycloalkyl, heterocycloalkyl, optionally substituted aryl, optionally substituted heteroaryl, cycloalkylalkyl, heterocycloalkylalkyl, optionally substituted arylalkyl, optionally substituted heteroarylalkyl,or optionally substituted aminoalkyl or R2 and R3, together with the carbon atom carrying them, form cycloalkyl or monocyclic heterocyclic group, substituted or unsubstituted, R40 represents hydrogen or a group selected from optionally substituted alkyl, optionally substituted alkenyl and optionally substituted alkynyl or Q or —V—Q wherein V represents alkylene, alkenylene or alkynylene and Q represents optionally substituted cycloalkyl, optionally substituted aryl, optionally substituted heterocycloalkyl,or optionally substituted heteroaryl, R41 and R5 together form a bond or each represents hydrogen, R6,
    Type: Grant
    Filed: October 22, 1999
    Date of Patent: February 26, 2002
    Assignee: Adir et Compagnie
    Inventors: Patrick Casara, Gilbert Dorey, Pierre Lestage, Brian Lockhart
  • Publication number: 20020022643
    Abstract: A compound selected from those of formula (I): 1
    Type: Application
    Filed: June 26, 2001
    Publication date: February 21, 2002
    Inventors: Solo Goldstein, Claude Guillonneau, Yves Charton, Brian Lockhart, Pierre Lestage
  • Patent number: 6323220
    Abstract: The invention relates to a compound of formula (I): wherein: A represents pyridine, pyridinium or piperidine R1, R2, R3 and R4 are as defined in the description R5 represents hydrogen, a nitrogen-containing heterocycle or a group of R6 represents hydrogen or linear or branched (C1-C6)alkyl. and medicinal products containing the same which are useful in treating pain or deficiencies in memory.
    Type: Grant
    Filed: May 4, 2000
    Date of Patent: November 27, 2001
    Assignee: Adir et Compagnie
    Inventors: Otto Meth-Cohn, Chu-Yi Yu, Pierre Lestage, Marie-Cécile Lebrun, Daniel-Henri Caignard, Pierre Renard
  • Patent number: 6323222
    Abstract: Compound of formula (I): wherein: n represents 0 or 1, R1 represents hydrogen, arylalkyl, alkyl, acyl, alkoxycarbonyl, arylalkoxycarbonyl or trifluoroacetyl, R2 represents alkyl, X represents oxygen, chlorine, OR3, SR4 or NOR5, R3 represents hydrogen, alkyl, acyl, alkoxycarbonyl or arylalkoxycarbonyl, R4 represents hydrogen, alkyl or aryl, R5 represents hydrogen or optionally substituted alkyl, represents a single or double bond, Ar represents aryl or heteroaryl, its isomers and addition salts thereof with a pharmaceutically acceptable acid, and medicinal products containing the same which are useful as facilitators of memory and cognition and antalgic agents.
    Type: Grant
    Filed: May 2, 2000
    Date of Patent: November 27, 2001
    Assignee: Adir et Compagnie
    Inventors: Sylvain Rault, Olivier Renault, Jean Guillon, Patrick Dallemagne, Pierre Renard, Bruno Pfeiffer, Pierre Lestage, Marie-Cécile Lebrun
  • Publication number: 20010031746
    Abstract: The invention relates to a compound of formula (I): 1
    Type: Application
    Filed: February 15, 2001
    Publication date: October 18, 2001
    Inventors: Alex Cordi, Patrice Desos, Pierre Lestage
  • Patent number: 6150358
    Abstract: A compound of formula (I): ##STR1## wherein Ra represents linear or branched (C.sub.1 -C.sub.8)alkylene,Rb represents single bond, or linear or branched (C.sub.1 -C.sub.6)alkylene,Z represents thiocarbamate, or thioamide, each being optionally substituted,T represents optionally substituted morpholino,its isomers, and pharmaceutically-acceptable acid or base addition salts thereof, and medicinal products containing the same which are useful in the treatment of disease for which the use of anti-oxidation agent is required.
    Type: Grant
    Filed: December 14, 1999
    Date of Patent: November 21, 2000
    Assignee: Adir et Compagnie
    Inventors: Solo Goldstein, Claude Guillonneau, Yves Charton, Pierre Lestage, Brian Lockhart
  • Patent number: 6034250
    Abstract: A compound selected from those of formula (1): ##STR1## wherein W represents aryl, arylalkyl, heteroaryl, or heteroarylalkyl, each being optionally substituted,R.sub.1 represents alkyl, alkenyl, alkynyl, aryl, cycloalkyl, arylalkyl, or cycloalkylalkyl, each being optionally substituted.R.sub.2 is as defined in the description,its isomers, and addition salts thereof with a pharmaceutically-acceptable acid or base, and medicinal products containing the same which are useful as anti-oxidation agents.
    Type: Grant
    Filed: June 25, 1999
    Date of Patent: March 7, 2000
    Assignee: Adir Et Compagnie
    Inventors: Solo Goldstein, Alain Dhainaut, Andre Tizot, Brian Lockhart, Pierre Lestage